Moreover, various reports have described activating mutations in the PIK3CA gene encoding the catalytic p110α isoform of PI3K in a variety of human cancers, including, breast, colon and ovarian cancer, as well as embryonal tumors [51], [54], [55]. This evidence concerns the gene PIK3CA and ovarian cancer.